Investor Relations

FAQs

Magellan's Annual Report discusses our vision to become a diversified specialty managed health care company that manages a greater portion of the health care dollar.

When the date is finalized for all calls, we publish it in a press release.

Magellan's transfer agent is:

American Stock Transfer & Trust Company
59 Maiden Lane
New York, NY 10038
1-800-937-5449 (toll-free)
1- 718-921-8124 (local, international)
Web Site www.amstock.com
Email investors@amstock.com

Please submit your question using the form below.

* Indicates required field

For additional information please see our most recent SEC filings and news releases.

NASDAQ: MGLN

55.49
+ 0.71 (1.30%)
4:00 PM ET on Sep 18, 2014
Delayed at least 20 minutes.

IR Contacts

Investor Contact
Renie Shapiro
Senior Vice President, Corporate Finance
(877) 645-6464
E-Mail: ir@MagellanHealth.com

American Stock Transfer & Trust Company
6201 15th Avenue
Brooklyn, New York 11219
(800) 937-5449 (toll-free)
(718) 921-8124 (local, international)
Web Site: www.amstock.com
E-Mail: info@amstock.com